Doximity, Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the quarter ended June 30, 2026, the Company’s directors and officers adopted orterminated prearranged trading plans intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act as follows:
On April 27, 2026, Ms. Anna Bryson, former Chief Financial Officer of the Company, terminated a Rule 10b5-1 trading plan that she had previously entered into on May 27, 2025. The plan, which was scheduled to expire pursuant to its terms on May 27, 2026, provided for the sale of up to 160,000 shares of the Company’s Class A common stock issuable upon the exercise of vested stock options. A total of 40,000 shares were sold under the plan prior to its termination.
On May 22, 2026, Ms. Phoebe Yang, adirector of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on October 14, 2026, providing for the sale of up to 1,290 shares of common stock.
On May 26, 2026, Ms. Kira Wampler, adirector of the Company, adopted a Rule 10b5-1 trading plan with a term expiring on May 26, 2028, providing for the sale of up to 54,000 shares of stock issuable upon the exercise of vested stock options.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.